Walleye Capital LLC Chemo Centryx, Inc. Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$22.17 - $51.8 $893,584 - $2.09 Million
40,306 New
40,306 $2.08 Million
Q2 2022

Aug 08, 2022
SELL
$15.36 - $27.51 $532,239 - $953,249
-34,651 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$22.22 - $39.12 $769,945 - $1.36 Million
34,651 New
34,651 $869,000
Q3 2021

Nov 15, 2021
SELL
$13.18 - $19.83 $250,367 - $376,690
-18,996 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$9.59 - $50.88 $182,171 - $966,516
18,996 New
18,996 $254,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email